genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
News
CRISPR Anticancer Tech Aids Immune System Surveillance and Attack
Natural Products
Coffee Extracts Improve Insulin Sensitivity
Neuroscience
Cannabis During Pregnancy Alters Offspring’s Brain in Rats
News
Sweet-Talking Slime Mollifies Pathogens
Insights
Commentary
Successfully Addressing the Challenges of Glycosylation
Brexit
Top 10 European Biopharma Clusters
Tech Exclusives
One-Stop-Shop Genome Editing Product Launched by Inscripta
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
A-Lists
Brexit
Top 10 European Biopharma Clusters
Insights
Top 10 U.S. Biopharma Clusters
Insights
10 Takeover Targets to Watch This Fall
Insights
What the Top 10 Biopharma CEOs Are Making
October 2019 Vol. 39 No. 10
Top 10 Companies Leveraging Gene Editing in 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
GE Healthcare, NIBRT Partner on Cell Therapy, Single-Use Bioprocessing
News
Sweet-Talking Slime Mollifies Pathogens
Five Prime Therapeutics
Five Prime Eliminates 70 Jobs in Restructuring
News
CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System
Magazine
All
Supplement
October 2019 Vol. 39 No. 10
Better Living through Molecular Neuropharmacology
October 2019 Vol. 39 No. 10
CRISPR Dx May Help Nix Disease
Tech Exclusives
Modular Bioprocessing Makes Adaptability a Snap
Tech Exclusives
A Nanomedicine Technology Sampler Pack
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
A Cultured Life: Innovations in Spheroid and Organoid Models
Posters
Microfluidic Diffusional Sizing: A Novel Method for Characterizing Protein Interactions
Drug Discovery
Importance of mAb Discovery and Development in Immunotherapy
eBooks
Sample Preparation for Quality Control: Solutions for Optimized Workflows and Accurate…
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Autoimmune Disease Drugs
Autoimmune Disease Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Autoimmune Disease Drugs
Critical Cellular Player Controlling HIV Reproduction in Immune Cells Identified
Autoimmune Disease Drugs
Novartis Gains Option to Acquire Second IFM Subsidiary in Up-to-$840M cGAS/STING Collaboration
Autoimmune Disease Drugs
Multiple Sclerosis Suppressed in Mouse Model by Oft-Overlooked Immune System Cell Type
Autoimmune Disease Drugs
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by Acquiring Tilos for Up to $773M
Autoimmune Disease Drugs
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Autoimmune Disease Drugs
Cellular Stress, Not Infection, May Rouse Slumbering MS-Linked Retroviruses
Autoimmune Disease Drugs
Lilly, Avidity to Partner on Immunology Drugs in Up-to-$440M Collaboration
Autoimmune Disease Drugs
Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration
Autoimmune Disease Drugs
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
Autoimmune Disease Drugs
argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Autoimmune Disease Drugs
Top 10 GEN News Articles of 2018
Autoimmune Disease Drugs
Lilly, Aduro to Develop STING Pathway Inhibitors for Autoimmune Diseases
Autoimmune Disease Drugs
Microbiome Modeling Reveals How Bacteria Shape Host Fitness
Autoimmune Disease Drugs
New Work Opens Door to Manipulating Aberrant Calcium Signaling in Immune...
Autoimmune Disease Drugs
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-324x160.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
